Ar. Korotzer et al., CULTURED RAT MICROGLIA EXPRESS C1Q AND RECEPTOR FOR C1Q - IMPLICATIONS FOR AMYLOID EFFECTS ON MICROGLIA, Experimental neurology, 134(2), 1995, pp. 214-221
Senile plaques, the pathological hallmark of Alzheimer's disease (AD),
are associated with complement components, including C1q. Reactive mi
croglia appear to be involved in the later stages of plaque developmen
t. Since tissue macrophages are known to synthesize C1q, cultured rat
microglia were examined for C1q immunoreactivity. Anti-C1q staining wa
s detected, particularly in process-bearing microglia, indicating cons
titutive expression of C1q. Thus, microglia could provide a source of
C1q for plaques even before becoming reactive. Since it has been previ
ously shown that C1q binds beta 1-42, the major constituent of senile
plaques, and since beta 1-42 is toxic to microglia in vitro, we asked
if preincubation of beta 1-42 with C1q alters either metabolic indices
of amyloid-induced degeneration in microglial cultures or the formati
on of amyloid deposits on these cells. While electron microscopic anal
ysis of negatively stained amyloid fibrils confirmed that preincubatio
n with C1q induced the association of C1q with the fibrils, no effect
of the binding of C1q to beta 1-42 on beta 1-42 toxicity in microglia
was observed. Interestingly, immunoreactivity for the C1q receptor tha
t is known to modulate phagocytosis was found and was up-regulated in
non-process-bearing microglia by interferon-gamma. While these data ex
clude a role for the C1q receptor in beta 1-42 toxicity in microglia,
the observed expression and up-regulation of C1q receptor oh microglia
by interferon-gamma would be consistent with a role for C1q in comple
ment-mediated inflammatory responses in AD and as a potential activato
r of microglial function in plaques. (C) 1995 Academic Press, Inc.